133 related articles for article (PubMed ID: 12484062)
1. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
Kasugai H; Katayama N; Sakai S; Yamakawa T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
3. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.
Kwak HS; Lee JM; Kim CS
Eur Radiol; 2004 Mar; 14(3):447-57. PubMed ID: 14531005
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
[TBL] [Abstract][Full Text] [Related]
5. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP.
Ba-Ssalamah A; Heinz-Peer G; Schima W; Schibany N; Schick S; Prokesch RW; Kaider A; Teleky B; Wrba F; Lechner G
J Magn Reson Imaging; 2000 Jun; 11(6):665-72. PubMed ID: 10862066
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
[TBL] [Abstract][Full Text] [Related]
8. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
[TBL] [Abstract][Full Text] [Related]
9. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
Tanimoto A; Kuribayashi S
Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
[TBL] [Abstract][Full Text] [Related]
10. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas.
Furuhata T; Okita K; Tsuruma T; Hata F; Kimura Y; Katsuramaki T; Mukaiya M; Hirokawa N; Ichimura T; Yama N; Koito K; Sasaki K; Hirata K
Dig Surg; 2003; 20(4):321-5. PubMed ID: 12806198
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
[TBL] [Abstract][Full Text] [Related]
14. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver.
Müller RD; Vogel K; Neumann K; Hirche H; Barkhausen J; Stöblen F; Henrich H; Langer R
Acta Radiol; 1999 Nov; 40(6):628-35. PubMed ID: 10598852
[TBL] [Abstract][Full Text] [Related]
15. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal hepatic lesions with SPIO-enhanced MRI.
Zheng WW; Zhou KR; Chen ZW; Shen JZ; Chen CZ; Zhang SJ
World J Gastroenterol; 2002 Feb; 8(1):82-6. PubMed ID: 11833077
[TBL] [Abstract][Full Text] [Related]
18. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
[TBL] [Abstract][Full Text] [Related]
19. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
